DRUG REGULATION NewsLatest News On DRUG REGULATION U.S. to Phase Out Common Decongestant, Finding It Ineffective12/24/2024 9:56 PM Europe Rejects Cinainu (Alopecia) and Kizfizo (Neuroblastoma)11/15/2024 11:42 AM Leqembi Okayed for Subset of Early Alzheimer’s Patients11/15/2024 10:34 AM Two Lung Cancer Drugs Recommended by EMA11/15/2024 10:34 AM Germany’s Medication Supply Issues Persist Despite New Law11/6/2024 6:28 AM EMA OKs Sublingual Formulation for Opioid Dependence10/18/2024 9:55 AM EMA Authorizes Korjuny for Malignant Ascites10/18/2024 8:41 AM Hympavzi Approved in Europe for Severe Hemophilia A and B9/20/2024 10:43 AM EMA Backs Approval of Elahere for Ovarian Cancer9/20/2024 9:46 AM New Combination Drug for Endometrial Cancer Approved in EU8/14/2024 12:21 PM EMA Says Don't Mix Mysimba and Opioid-Containing Meds7/26/2024 11:42 AM Anzupgo Approved in Europe for Severe Hand Eczema7/26/2024 9:47 AM EU Backs Drug to Relieve Itching in Alagille Syndrome7/26/2024 9:47 AM EMA Backs Oral Drug for Primary Biliary Cholangitis7/26/2024 8:50 AM EMA Refuses Marketing Authorization for Alzheimer's Drug7/26/2024 8:50 AM EU OKs First-Line Osimertinib + Chemo for EGFR+ Advanced NSCLC7/5/2024 9:23 AM Europe Endorses Its First mRNA Vaccine for RSV6/28/2024 12:15 PM EMA Greenlights Four Drugs for Bladder and Other Cancers6/28/2024 11:19 AM Pulmonary Arterial Hypertension Drug OK'd by Europe6/28/2024 9:33 AM New Drugs Turned Down by EU Safety Assessor6/28/2024 9:32 AM
